Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Thielen, Monika
NCT02261883 / 2023-001028-40: Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn	Terminated	2	42	US	IV Remodulin, Treprostinil, Placebo	United Therapeutics, United Therapeutics Corp	Persistent Pulmonary Hypertension of the Newborn	09/22	05/23
NCT03969992: A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact	Completed	2	261	Canada, US	AeroFact, SF-RI 1, nCPAP	Aerogen Pharma Limited	Respiratory Distress Syndrome in Premature Infant	08/23	08/24
Swanson, Jonathan R
NCT02261883 / 2023-001028-40: Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn	Terminated	2	42	US	IV Remodulin, Treprostinil, Placebo	United Therapeutics, United Therapeutics Corp	Persistent Pulmonary Hypertension of the Newborn	09/22	05/23
NCT05914064: Gravitas Feeding Tube System Placement Validation in Neonates	Recruiting	N/A	110	US	Gravitas FT and Gravitas FT Monitor guidance, Gravitas FT System without placement guidance	Gravitas Medical, Inc.	Nasogastric Tube	09/24	12/24